- Home
- KIRK vs LGVN Comparison
KIRK vs LGVN Comparison
Compare KIRK & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIRK
- LGVN
- Stock Information
- Founded
- KIRK 1966
- LGVN 2014
- Country
- KIRK United States
- LGVN United States
- Employees
- KIRK N/A
- LGVN N/A
- Industry
- KIRK Diversified Commercial Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- KIRK Miscellaneous
- LGVN Health Care
- Exchange
- KIRK Nasdaq
- LGVN Nasdaq
- Market Cap
- KIRK 26.7M
- LGVN 23.4M
- IPO Year
- KIRK 2002
- LGVN 2021
- Fundamental
- Price
- KIRK $1.16
- LGVN $1.47
- Analyst Decision
- KIRK Buy
- LGVN Strong Buy
- Analyst Count
- KIRK 2
- LGVN 3
- Target Price
- KIRK $4.50
- LGVN $8.67
- AVG Volume (30 Days)
- KIRK 195.7K
- LGVN 715.2K
- Earning Date
- KIRK 09-04-2025
- LGVN 08-13-2025
- Dividend Yield
- KIRK N/A
- LGVN N/A
- EPS Growth
- KIRK N/A
- LGVN N/A
- EPS
- KIRK N/A
- LGVN N/A
- Revenue
- KIRK $431,111,000.00
- LGVN $2,225,000.00
- Revenue This Year
- KIRK N/A
- LGVN N/A
- Revenue Next Year
- KIRK N/A
- LGVN $51.48
- P/E Ratio
- KIRK N/A
- LGVN N/A
- Revenue Growth
- KIRK N/A
- LGVN 127.50
- 52 Week Low
- KIRK $1.05
- LGVN $1.14
- 52 Week High
- KIRK $2.50
- LGVN $4.88
- Technical
- Relative Strength Index (RSI)
- KIRK 49.42
- LGVN 57.16
- Support Level
- KIRK $1.16
- LGVN $1.37
- Resistance Level
- KIRK $1.23
- LGVN $1.40
- Average True Range (ATR)
- KIRK 0.04
- LGVN 0.12
- MACD
- KIRK 0.01
- LGVN 0.02
- Stochastic Oscillator
- KIRK 58.82
- LGVN 47.70
About KIRK Kirkland's Inc. COMMONSTOCK
Kirkland's Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.